|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 2011-02-28 |
| Corporate Officer/Principal | - | 2011-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 2011-02-28 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | -5.59% | +37.54% | -6.24% | 79.21B | |
| -1.42% | -4.24% | -18.81% | -37.78% | 58.22B | |
| +5.38% | -1.09% | +467.03% | +36.08% | 54.54B | |
| -0.56% | -2.21% | -11.17% | +25.38% | 48.89B | |
| +1.93% | -2.37% | -2.00% | +149.45% | 44.72B | |
| +0.80% | -1.67% | +45.89% | -16.13% | 31.83B | |
| -1.47% | -4.17% | +40.97% | +88.59% | 24.99B | |
| -0.85% | -8.64% | -3.66% | +144.26% | 20.95B | |
| -0.09% | -3.61% | +63.58% | +97.66% | 15.8B | |
| Average | +0.25% | -3.83% | +68.82% | +53.47% | 42.13B | |
| Weighted average by Cap. | +0.32% | -3.63% | +79.47% | +35.51% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
